New FDA Program to Focus on Driving Rare Disease Drug Development
June 16, 2022: New FDA Program to Focus on Driving Rare Disease Drug Development
This author has not written his bio yet.
But we are proud to say that Bhushan Sreekrishnavilas contributed 237 entries already.
June 16, 2022: New FDA Program to Focus on Driving Rare Disease Drug Development
June 14, 2022: Can FDA replicate Operation Warp Speed for rare diseases? Not yet, but Peter Marks has some ideas
Urano publishes research on the connection between loss of WFS1 function and ER stress-mediated inflammation
June 7, 2022: Vegan Diet Aids Weight Loss in People With Diabetes
June 2, 2022: 12 Best Diabetic Snacks | US News
May 26, 2022: Top 12 Emerging Gene and Cell Therapy Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham
May 24, 2022: Oramed hits oral insulin clinical trial milestone
May 19, 2022: Blind people could one day see with high-tech glasses (which have the backing of Stevie Wonder!) | Daily Mail Online
May 17, 2022: New Evidence Shows How Exercise Can Counter Diabetes Damage
May 12, 2022: Alzheimer’s Research Casts Doubt on Safety of Popular Brain Supplements – Consumer Health News | HealthDay
The Snow Foundation is a collective voice for Wolfram syndrome patients, working towards a cure for Wolfram syndrome and developing novel therapies for diabetes, vision loss, hearing loss and neurodegeneration.
P.O. Box 50224 Clayton, MO 63105
(402) 694-1354
You must be logged in to post a comment.